Anthem's Defense In $54B Merger Trial Met With Skepticism
A D.C. federal judge appeared dissatisfied with the evidence Anthem Inc. has put forth to show that its $54 billion proposed merger with Cigna Corp. wouldn't harm competition during a rare...To view the full article, register now.
Already a subscriber? Click here to view full article